<SEC-DOCUMENT>0000920465-20-000055-index.html : 20200429
<SEC-HEADER>0000920465-20-000055.hdr.sgml : 20200429
<ACCEPTANCE-DATETIME>20200429170659
ACCESSION NUMBER:		0000920465-20-000055
CONFORMED SUBMISSION TYPE:	DEF 14A
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20200625
FILED AS OF DATE:		20200429
DATE AS OF CHANGE:		20200429
EFFECTIVENESS DATE:		20200429

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			LA JOLLA PHARMACEUTICAL CO
		CENTRAL INDEX KEY:			0000920465
		STANDARD INDUSTRIAL CLASSIFICATION:	BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
		IRS NUMBER:				330361285
		STATE OF INCORPORATION:			CA
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		DEF 14A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-36282
		FILM NUMBER:		20831447

	BUSINESS ADDRESS:	
		STREET 1:		4550 TOWNE CENTRE COURT
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
		BUSINESS PHONE:		858-207-4264

	MAIL ADDRESS:	
		STREET 1:		4550 TOWNE CENTRE COURT
		CITY:			SAN DIEGO
		STATE:			CA
		ZIP:			92121
</SEC-HEADER>
<DOCUMENT>
<TYPE>DEF 14A
<SEQUENCE>1
<FILENAME>proxy2020.htm
<DESCRIPTION>DEF 14A
<TEXT>
Document 1 - file: proxy2020.htm

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>2
<FILENAME>image1a08.jpg
<TEXT>
Document 2 - file: image1a08.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>lajolla2019proxycard01page1.jpg
<TEXT>
Document 3 - file: lajolla2019proxycard01page1.jpg

</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>4
<FILENAME>lajolla2019proxycard01page2.jpg
<TEXT>
Document 4 - file: lajolla2019proxycard01page2.jpg

</DOCUMENT>
</SEC-DOCUMENT>